Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
D. Miller, H. Muellerova, T. Sampson, R. Baxter, K. Davis (Research Triangle Park, United States Of America; Greenford, United Kingdom). COPD medications and risk of pneumonia in the UK. Eur Respir J 2008; 32: Suppl. 52, 1157

Member's Comments

No comment yet.

Related content which might interest you: Exacerbations and mortality of COPD patients with cardiovascular disease in the UK Source: Annual Congress 2010 - Comorbidity in obstructive airway disease Year: 2010 Inhaled corticosteroids and the risk of pneumonia in Medicare patients with COPD Source: Annual Congress 2012 - COPD: risk factors, biomarkers and diagnosis Year: 2012 β-blockers and risk of COPD exacerbation requiring hospitalisation in patients with COPD Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia Source: International Congress 2014 – COPD exacerbations Year: 2014 COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 The risk of hyperkalemia in COPD and asthma patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Cardiovascular medications and mortality in patients hospitalised with acute exacerbations of COPD Source: Annual Congress 2013 –COPD biomarkers Year: 2013 Clinical and demographic factors associated with pneumonia risk in a COPD patient cohort Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Incidence and risk factors of acute exacerbations of COPD in Italy Source: Eur Respir J 2001; 18: Suppl. 33, 152s Year: 2001 The prevalence of co-morbidities and exacerbations in COPD patients in Slovenia Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 Risk factors for another hospitalization in COPD patients hospitalized for exacerbation Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Risk factors of mortality in COPD patients with ventilator associated pneumonia Source: Eur Respir J 2007; 30: Suppl. 51, 50s Year: 2007 Co-morbidities in patients with COPD in the UK Source: Eur Respir J 2003; 22: Suppl. 45, 375s Year: 2003 Out-patient combination therapy with inhaled corticosteroids and bronchodilators is associated with lower in-hospital mortality in pneumonia in patient with COPD Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD Year: 2016 Pneumonia risk in COPD patients on long term inhaled corticosteroids – Data from the European COPD audit<% Source: Annual Congress 2013 –Guidelines and exacerbations Year: 2013 Factors associated with COPD exacerbation frequency in a UK primary care cohort Source: Annual Congress 2013 –Risk factors for COPD and lung function decline Year: 2013 Characteristics and prognostic factors associated with cardiovascular (CV) comorbidity in COPD patients hospitalized for acute exacerbation (AECOPD) Source: Annual Congress 2013 –COPD mechanisms Year: 2013 Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia Source: Eur Respir J 2010; 36: 751-757 Year: 2010 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013